- Home
- CODX vs CMBM Comparison
CODX vs CMBM Comparison
Compare CODX & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODX
- CMBM
- Stock Information
- Founded
- CODX 2013
- CMBM 2011
- Country
- CODX United States
- CMBM United States
- Employees
- CODX N/A
- CMBM N/A
- Industry
- CODX Medical/Dental Instruments
- CMBM Radio And Television Broadcasting And Communications Equipment
- Sector
- CODX Health Care
- CMBM Technology
- Exchange
- CODX Nasdaq
- CMBM Nasdaq
- Market Cap
- CODX 23.6M
- CMBM 26.5M
- IPO Year
- CODX 2017
- CMBM 2019
- Fundamental
- Price
- CODX $0.73
- CMBM $0.72
- Analyst Decision
- CODX Hold
- CMBM Strong Buy
- Analyst Count
- CODX 1
- CMBM 3
- Target Price
- CODX $1.50
- CMBM $5.50
- AVG Volume (30 Days)
- CODX 187.1K
- CMBM 185.1K
- Earning Date
- CODX 11-07-2024
- CMBM 02-13-2025
- Dividend Yield
- CODX N/A
- CMBM N/A
- EPS Growth
- CODX N/A
- CMBM N/A
- EPS
- CODX N/A
- CMBM N/A
- Revenue
- CODX $7,321,012.00
- CMBM $172,215,000.00
- Revenue This Year
- CODX N/A
- CMBM N/A
- Revenue Next Year
- CODX N/A
- CMBM $16.49
- P/E Ratio
- CODX N/A
- CMBM N/A
- Revenue Growth
- CODX 57.16
- CMBM N/A
- 52 Week Low
- CODX $0.70
- CMBM $0.66
- 52 Week High
- CODX $2.23
- CMBM $6.50
- Technical
- Relative Strength Index (RSI)
- CODX 24.04
- CMBM 29.36
- Support Level
- CODX $0.70
- CMBM $0.68
- Resistance Level
- CODX $0.87
- CMBM $0.81
- Average True Range (ATR)
- CODX 0.06
- CMBM 0.11
- MACD
- CODX -0.00
- CMBM -0.03
- Stochastic Oscillator
- CODX 12.00
- CMBM 10.79
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.